This is a preview of subscription content, log in via an institution to check access.
Notes
including ciprofloxacin, moxifloxacin, levofloxacin, norfloxacin and ofloxacin
Reference
Health Canada. Summary Safety Review - Fluoroquinolones - Assessing the potential risk of persistent and disabling side effects. Internet Document : 23 Jan 2017. Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/reviews-examens/fluoroquinolones2-eng.php
Rights and permissions
About this article
Cite this article
Known rare ADRs of FQs "may be persistent and/or disabling". Reactions Weekly 1637, 4 (2017). https://doi.org/10.1007/s40278-017-25887-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-25887-3